Previously, the Drug Administration of Vietnam reported information from Sandoz Vietnam Co., Ltd. about a suspected case of counterfeit drugs for Aclasta products, circulation license number: 9001101700.
The report stated that on July 16, 2025, Sandoz Vietnam Co., Ltd. received a complaint from a pharmacy at the Family Medical Tools Clinic, address G2-41 Pham Hung, An Hoa Ward, Rach Gia City, Kien Giang (according to the old address), a customer came to the pharmacy to ask about Aclasta products and shared a picture of the product's packaging.
From the information on the product image, Sandoz Vietnam Co., Ltd. and Aclasta Pharmaceutical Factory registered in Vietnam verified that the shipment was not manufactured by Sandoz's factory and was not imported by Sandoz Vietnam Co., Ltd. The shipments manufactured after May 2024 no longer have the Novartis logo on the label but instead the Sandoz logo. The company suspected the product was a fake drug.
In order to ensure the safety of users and promptly detect and prevent counterfeit products from circulating on the market, the Ho Chi Minh City Department of Health recommends: Pharmaceutical businesses, medical examination and treatment facilities, non-business establishments, and users of Aclasta drugs with production date after May 2024 have Novartis logos. When discovering a product with the above characteristics circulating on the market, it is recommended that organizations/individuals immediately notify the Department of Health and relevant agencies for timely inspection and handling according to regulations.
Review and check the entire list of drugs in business and used at the unit, ensure that they are not used or traded in counterfeit drugs, drugs of unknown origin, drugs that are not yet authorized for circulation, or drugs that do not meet quality standards. Do business within the licensed scope, only do business in and use goods that are allowed to circulate, with invoices, documents, and documents of correct origin.
